Targovax is engaged in developing and commercializing novel immuno-oncology therapies for the treatment of solid tumors and cancer.
Business Model:
Revenue: $4.4k
Employees: 11-50
Address: Lilleakerveien 2 C
City: Oslo
State: oslo
Zip: NO-0283
Country: NO
Targovax is engaged in developing and commercializing novel immuno-oncology therapies for the treatment of solid tumors and cancer.
Contact Phone:
Contact Email:
Listed Exchange:
FRA
IPO Date:
1/1/2015
Ticker Symbol:
TRVX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2013 | Funding Round | $0 |
Radium Hospital Research Foundation Algot Invest Trygve Schiorbeck Radium Hospital Research Foundation Algot Invest Trygve Schiorbeck |
2/2012 | Series A | $0 |
Birk Venture Birk Venture Birk Venture Birk Venture |
7/2016 | Post-IPO Equity | $23.5M | 1/2022 | Grant | 1 | $946.1k |
Innovation Norway Innovation Norway Innovation Norway Innovation Norway |
6/2017 | Private Placement | $23.6M | 6/2016 | Private Placement | $13.3M | 1/2012 | Series A | $2.2M |
Radium Hospital Research Foundation Birk Venture RO Invest |
6/2013 | Equity | 3 | $3.6M |
Radium Hospital Research Foundation Radium Hospital Research Foundation Algot Invest Trygve Schiorbeck |
2/2012 | Series A | 1 | $2.2M |
Birk Venture Birk Venture Birk Venture Birk Venture |
---|
Announced Date | Name | Price |
---|---|---|
7/2015 | Oncos Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|